Articles filed under 'ADHD'
Children who are mixed-handed, or ambidextrous, are more likely to have mental health, language and scholastic problems in childhood than right- or left-handed children, according to a new study. The researchers behind the study suggest that their findings may help teachers and health professionals to identify children who are particularly at risk of developing certain problems.
Continue Reading
February 14th, 2011
Rising rates of attention deficit hyperactivity disorder and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study demonstrates that these concerns are justified. Researchers found large discrepancies in diagnosis and treatment rates based on small differences in children’s dates of birth.
Continue Reading
February 11th, 2011
A new study suggests a trend toward developing hyperactivity among typically developing elementary-school-aged siblings of autistic preschoolers and supports the notion that mothers of young, autistic children experience more depression and stress than mothers with typically developing children.
Continue Reading
February 6th, 2011
Although it’s typically considered an adolescent curse, ADHD actually affects about five percent of adults as well. New research in a mouse model of attention deficit/hyperactivity disorder suggests that the root of the psychiatric disorder might be the over-activity of a protein that regulates dopaminergic pathways. The work suggests a path toward new treatments for symptoms including inattentiveness, over-activity and impulsivity.
Continue Reading
January 18th, 2011
Children with fetal alcohol exposure often exhibit similar symptoms to those with ADHD, but new research indicates that they actually occur in completely different areas within the brain.
Continue Reading
January 10th, 2011
ADHD may be caused by alterations in the serotonin neurotransmission system combined with a tendency to experience psychosocial distress. Researchers found that ADHD behaviors in children and adolescents were associated with interactions between low and high serotonin activity and self-blame in relation to inter-parental conflict.
Continue Reading
December 21st, 2010
A new study shows that use of psychotropic medications is common among children with ASD, with 27 percent of those enrolled in the network registry receiving at least one medication to manage their behavior. The most common reasons for medication use were hyperactivity, repetitive behaviors, irritability and attentional concerns.
Continue Reading
December 13th, 2010
ADHD, or attention-deficit/hyperactivity disorder, is among the costliest of behavioral disorders. New research suggests that the culprit may be an old villain — lead — and what’s more it explains the causal pathway from exposure to disability.
Continue Reading
December 10th, 2010
ADHD, or attention-deficit/hyperactivity disorder, is among the costliest of behavioral disorders. New research suggests that the culprit may be an old villain — lead — and what’s more it explains the causal pathway from exposure to disability.
Continue Reading
December 9th, 2010
The FDA recently approved a new amphetamine-based drug for hyperactivity disorder that will be harder to abuse than older stimulants, according to pharmaceutical company Shire. Vyvanse remains inactive until swallowed, after which it gradually releases its active ingredient d-amphetamine. It is activated after coming into contact with enzymes in the digestive tract.
Vyvase is expected to stop the potential for abuse by individuals who snort or inject crushed pills. The newly developed drug will be listed as a Schedule II drug, a category including cocaine, methadone, methamphetamines, and other ADHD medicines such as Adderall and Ritalin. Vyvanse will carry a “black-box†warning because of safety concerns related to amphetamine abuse, as well as the risk of sudden death in patients with heart defects.
The FDA approval of Vyvanse took place in the same week when the agency required manufacturers of other ADHD drugs to warn patients and parents of potential mental and heart problems associated with these medications in a small percentage of users.
FDA statistics indicate that ADHD affects about 3 to 7% of schoolchildren and 4% of adults. The principal symptoms are hyperactive behavior, difficulty paying attention, and problems with impulse control. Medications approved to treat ADHD have major benefits for many patients but for some, they can also pose serious risks.
New warning instructions required for ADHD medications will be included for Adderall, Concerta, Daytrana, Dexedrine, Focalin, Metadate, Methylin, Ritalin, and Strattera. It is hoped these new cautionary guidelines will not keep people who need these drugs from taking them.
Sources:Â Yahoo News; Medical News Today
February 27th, 2007
Next Posts
Previous Posts
